Mallen, & Roddy. (2017). Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol st…. BMJ Open, https://doi.org/10.1136/bmjopen-2017-017121